Showing results (451-460 of 2,692) with videos related to

Sort By:
Pageof 270
Schweizerische Medizinische Wochenschrift|February 26, 1983
[Problems of intravenous urography in patients with plasmocytoma]W Gassmann, T Haferlach, N Schmitz, et al.
Kidney International|February 1, 1997
The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsiveI Kvietikova, R H Wenger, H H Marti, et al.
Drug Discovery Today|May 9, 2021
Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligenceAlexander Schuhmacher, Alexander Gatto, Michael Kuss, et al.
The Science of the Total Environment|June 30, 2015
Physico-chemical characteristics affect the spatial distribution of pesticide and transformation product loss to an agricultural brookM Gassmann, O Olsson, C Stamm, et al.
Plos One|August 16, 2016
Kinetic mRNA Profiling in a Rat Model of Left-Ventricular Hypertrophy Reveals Early Expression of Chemokines and Their ReceptorsSimona Nemska, Laurent Monassier, Max Gassmann, et al.
Pharmaceutica Acta Helvetiae|December 1, 1996
Special considerations concerning regulatory requirements and drug development for peptides and biotech products in the EUA Braun, R Gassmann, K Kraus, et al.
The Journal of Membrane Biology|September 23, 2003
Pivotal role of reduced glutathione in oxygen-induced regulation of the Na(+)/K(+) pump in mouse erythrocyte membranesA Y Bogdanova, O O Ogunshola, C Bauer, et al.
Infection and Immunity|August 1, 1991
Phenotypic and genotypic analysis of Borrelia burgdorferi isolates from various sourcesT Adam, G S Gassmann, C Rasiah, et al.
International Journal of Molecular Medicine|December 18, 1998
Optimal erythropoietin expression in human hepatoma cell lines requires activation of multiple signalling pathwaysR H Wenger, H H Marti, C Bauer, et al.
Drug Discovery Today|February 3, 2025
A case study assessing the impact of M&A and licensing on FDA drug approvals of leading pharmaceutical companiesAlexander Schuhmacher, Kyrylo Grinchenko, Oliver Gassmann, et al.
Pageof 270